2Reynolds S C,St Aubin L B,Sabbadini L G. Reduced lung lesions in pigs challenged 25 weeks after the administration of a single dose of Mycoplasma hyopneumoniae vaccine at approximately 1 week of age[J].{H}Veterinary Journal,2009,(3):312-320.
3辉瑞产品公司.用于疫苗中的佐剂[P],US CN0010117582000.
4Maes D,Segales J,Meyns T. Control of Mycoplasma hyopneumoniae infections in pigs[J].{H}Veterinary Microbiology,2008,(4):297-309.
5Thacker E L,Thacker B J,Boettcher T B. Comparison of antibody prodection,lymphocyte stimulation,and protection induced by four commercial Mycoplasma hyopneumoniae bacterins[J].{H}JOURNAL OF SWINE HEALTH AND PRODUCTION,1998,(3):107-112.
6Krashias G,Simon A K,Wegmann F. Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer[J].{H}VACCINE,2010,(13):2482-2489.
7Nordengrahn A,Rusvai M,Merza M. Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals:prevention of the bifactorial disease with EHV-2 immunostimulating complexes[J].{H}Veterinary Microbiology,1996,(1):55-68.
8Fekadu M,Shaddock J H,Ekstrom J. An immune stimulating complex (ISCOM) subunit rabies vaccine protects dogs and mice against street rabies challenge[J].{H}VACCINE,1992,(3):192-197.
